Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevoflurane vs Isoflurane for emergence agitation after pediatric herniorrhaphy
IRCT20170515033986N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Sep 2018
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sevoflurane and isoflurane in Emergence agitation (EA) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Emergence agitation incidence. Started Sep 2018; status: completed.
02
Drugs
sevofluraneisoflurane
03
Conditions
Emergence agitation (EA)
Beyond the preview
Go deeper on IRCT20170515033986N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170515033986N2.